Fresenius – Capital Expenditure

Quarterly charts & data from official filings

Timeframe

Capital expenditure

Capital expenditureTable view

Earnings release date
Capital expenditure
Earnings release date:06 May. 26
Capital expenditure:
196,000,000 €-59.2%
Earnings release date:25 Mar. 26
Capital expenditure:
480,000,000 €+104.3%
Earnings release date:05 Nov. 25
Capital expenditure:
235,000,000 €+11.4%
Earnings release date:06 Aug. 25
Capital expenditure:
211,000,000 €+17.9%
Earnings release date:07 May. 25
Capital expenditure:
179,000,000 €-49.3%
Earnings release date:26 Mar. 25
Capital expenditure:
353,000,000 €+52.8%
Earnings release date:06 Nov. 24
Capital expenditure:
231,000,000 €+62.7%
Earnings release date:31 Jul. 24
Capital expenditure:
142,000,000 €-27.9%
Earnings release date:08 May. 24
Capital expenditure:
197,000,000 €-50.4%
Earnings release date:14 Mar. 24
Capital expenditure:
397,000,000 €+19.6%
Earnings release date:06 Nov. 23
Capital expenditure:
332,000,000 €-17.2%
Earnings release date:04 Aug. 23
Capital expenditure:
401,000,000 €+12.0%
Earnings release date:11 May. 23
Capital expenditure:
358,000,000 €-51.0%
Earnings release date:23 Mar. 23
Capital expenditure:
730,000,000 €+89.1%
Earnings release date:03 Nov. 22
Capital expenditure:
386,000,000 €-12.1%
Earnings release date:04 Aug. 22
Capital expenditure:
439,000,000 €+21.3%
Earnings release date:06 May. 22
Capital expenditure:
362,000,000 €

Revenue by segment

Revenue by segmentTable view

Earnings release date
Fresenius Medical Care (→ FME)
Fresenius Kabi
Fresenius Helios
Fresenius Vamed
Corporate/Other
Total
Earnings release date:06 May. 26
Fresenius Medical Care (→ FME):
–
Fresenius Kabi:
2,150,000,000 €-2.9%
Fresenius Helios:
3,501,000,000 €-1.3%
Fresenius Vamed:
–
Corporate/Other:
93,000,000 €-19.1%
Total:
5,744,000,000 €-2.2%
Earnings release date:25 Mar. 26
Fresenius Medical Care (→ FME):
–
Fresenius Kabi:
2,214,000,000 €+3.4%
Fresenius Helios:
3,546,000,000 €+9.4%
Fresenius Vamed:
–
Corporate/Other:
115,000,000 €+19.8%
Total:
5,875,000,000 €+7.3%
Earnings release date:05 Nov. 25
Fresenius Medical Care (→ FME):
–
Fresenius Kabi:
2,141,000,000 €+1.4%
Fresenius Helios:
3,240,000,000 €-3.9%
Fresenius Vamed:
–
Corporate/Other:
96,000,000 €+6.7%
Total:
5,477,000,000 €-1.7%
Earnings release date:06 Aug. 25
Fresenius Medical Care (→ FME):
–
Fresenius Kabi:
2,111,000,000 €-1.6%
Fresenius Helios:
3,370,000,000 €-0.7%
Fresenius Vamed:
–
Corporate/Other:
90,000,000 €-1.1%
Total:
5,571,000,000 €-1.1%
Earnings release date:07 May. 25
Fresenius Medical Care (→ FME):
–
Fresenius Kabi:
2,146,000,000 €-0.1%
Fresenius Helios:
3,394,000,000 €+3.7%
Fresenius Vamed:
–
Corporate/Other:
91,000,000 €-13.3%
Total:
5,631,000,000 €+1.9%
Earnings release date:26 Mar. 25
Fresenius Medical Care (→ FME):
–
Fresenius Kabi:
2,148,000,000 €+1.6%
Fresenius Helios:
3,273,000,000 €+6.2%
Fresenius Vamed:
–
Corporate/Other:
105,000,000 €-1.9%
Total:
5,526,000,000 €+4.2%
Earnings release date:06 Nov. 24
Fresenius Medical Care (→ FME):
–
Fresenius Kabi:
2,114,000,000 €+0.6%
Fresenius Helios:
3,082,000,000 €-4.6%
Fresenius Vamed:
–
Corporate/Other:
107,000,000 €+28.9%
Total:
5,303,000,000 €-2.1%
Earnings release date:31 Jul. 24
Fresenius Medical Care (→ FME):
–
Fresenius Kabi:
2,101,000,000 €+2.4%
Fresenius Helios:
3,230,000,000 €+1.4%
Fresenius Vamed:
–
Corporate/Other:
83,000,000 €+190.2%
Total:
5,414,000,000 €-5.1%
Earnings release date:08 May. 24
Fresenius Medical Care (→ FME):
–
Fresenius Kabi:
2,051,000,000 €+2.8%
Fresenius Helios:
3,184,000,000 €-0.1%
Fresenius Vamed:
561,000,000 €-5.7%
Corporate/Other:
-92,000,000 €+8.9%
Total:
5,704,000,000 €+0.5%
Earnings release date:14 Mar. 24
Fresenius Medical Care (→ FME):
–
Fresenius Kabi:
1,996,000,000 €-1.2%
Fresenius Helios:
3,188,000,000 €+8.0%
Fresenius Vamed:
595,000,000 €-8.0%
Corporate/Other:
-101,000,000 €+1.9%
Total:
5,678,000,000 €+2.9%
Earnings release date:06 Nov. 23
Fresenius Medical Care (→ FME):
–
Fresenius Kabi:
2,021,000,000 €+1.0%
Fresenius Helios:
2,953,000,000 €-5.1%
Fresenius Vamed:
647,000,000 €+21.8%
Corporate/Other:
-103,000,000 €+7.2%
Total:
5,518,000,000 €-46.7%
Earnings release date:04 Aug. 23
Fresenius Medical Care (→ FME):
4,825,000,000 €+2.6%
Fresenius Kabi:
2,001,000,000 €+0.5%
Fresenius Helios:
3,113,000,000 €+1.5%
Fresenius Vamed:
531,000,000 €-8.9%
Corporate/Other:
-111,000,000 €+6.7%
Total:
10,359,000,000 €+1.3%
Earnings release date:11 May. 23
Fresenius Medical Care (→ FME):
4,704,000,000 €-5.9%
Fresenius Kabi:
1,991,000,000 €-2.2%
Fresenius Helios:
3,066,000,000 €+1.2%
Fresenius Vamed:
583,000,000 €-18.1%
Corporate/Other:
-119,000,000 €+10.5%
Total:
10,225,000,000 €-3.9%
Earnings release date:23 Mar. 23
Fresenius Medical Care (→ FME):
4,997,000,000 €-1.9%
Fresenius Kabi:
2,036,000,000 €-1.7%
Fresenius Helios:
3,031,000,000 €+7.1%
Fresenius Vamed:
712,000,000 €+24.5%
Corporate/Other:
-133,000,000 €-22.0%
Total:
10,643,000,000 €+1.8%
Earnings release date:03 Nov. 22
Fresenius Medical Care (→ FME):
5,096,000,000 €+7.1%
Fresenius Kabi:
2,071,000,000 €+9.2%
Fresenius Helios:
2,829,000,000 €-3.3%
Fresenius Vamed:
572,000,000 €+1.8%
Corporate/Other:
-109,000,000 €+10.7%
Total:
10,459,000,000 €+4.4%
Earnings release date:04 Aug. 22
Fresenius Medical Care (→ FME):
4,757,000,000 €+4.6%
Fresenius Kabi:
1,896,000,000 €+2.7%
Fresenius Helios:
2,925,000,000 €-0.2%
Fresenius Vamed:
562,000,000 €+9.6%
Corporate/Other:
-122,000,000 €-2.5%
Total:
10,018,000,000 €+3.1%
Earnings release date:06 May. 22
Fresenius Medical Care (→ FME):
4,548,000,000 €
Fresenius Kabi:
1,847,000,000 €
Fresenius Helios:
2,931,000,000 €
Fresenius Vamed:
513,000,000 €
Corporate/Other:
-119,000,000 €
Total:
9,720,000,000 €

Revenue by geographic location

Revenue by geographic locationTable view

Earnings release date
North America
Europe
Asia-Pacific
Latin America
Africa
Total
Earnings release date:06 May. 26
North America:
663,000,000 €-8.3%
Europe:
4,340,000,000 €-1.6%
Asia-Pacific:
374,000,000 €+1.6%
Latin America:
326,000,000 €-2.1%
Africa:
41,000,000 €+0.0%
Total:
5,744,000,000 €-2.2%
Earnings release date:25 Mar. 26
North America:
723,000,000 €+12.4%
Europe:
4,410,000,000 €+8.8%
Asia-Pacific:
368,000,000 €-3.9%
Latin America:
333,000,000 €-5.1%
Africa:
41,000,000 €-8.9%
Total:
5,875,000,000 €+7.3%
Earnings release date:05 Nov. 25
North America:
643,000,000 €-5.3%
Europe:
4,055,000,000 €-2.3%
Asia-Pacific:
383,000,000 €+6.4%
Latin America:
351,000,000 €+3.2%
Africa:
45,000,000 €+12.5%
Total:
5,477,000,000 €-1.7%
Earnings release date:06 Aug. 25
North America:
679,000,000 €-1.9%
Europe:
4,152,000,000 €-0.1%
Asia-Pacific:
360,000,000 €-8.6%
Latin America:
340,000,000 €-3.1%
Africa:
40,000,000 €+8.1%
Total:
5,571,000,000 €-1.1%
Earnings release date:07 May. 25
North America:
692,000,000 €-1.0%
Europe:
4,157,000,000 €+2.4%
Asia-Pacific:
394,000,000 €+0.5%
Latin America:
351,000,000 €+6.0%
Africa:
37,000,000 €-15.9%
Total:
5,631,000,000 €+1.9%
Earnings release date:26 Mar. 25
North America:
699,000,000 €+2.6%
Europe:
4,060,000,000 €+6.2%
Asia-Pacific:
392,000,000 €-3.4%
Latin America:
331,000,000 €-6.2%
Africa:
44,000,000 €+10.0%
Total:
5,526,000,000 €+4.2%
Earnings release date:06 Nov. 24
North America:
681,000,000 €+5.3%
Europe:
3,823,000,000 €-2.2%
Asia-Pacific:
406,000,000 €-2.2%
Latin America:
353,000,000 €-13.1%
Africa:
40,000,000 €+5.3%
Total:
5,303,000,000 €-2.1%
Earnings release date:31 Jul. 24
North America:
647,000,000 €-4.0%
Europe:
3,908,000,000 €-7.9%
Asia-Pacific:
415,000,000 €+6.1%
Latin America:
406,000,000 €+14.7%
Africa:
38,000,000 €-13.6%
Total:
5,414,000,000 €-5.1%
Earnings release date:08 May. 24
North America:
674,000,000 €-9.3%
Europe:
4,241,000,000 €+2.0%
Asia-Pacific:
391,000,000 €+20.7%
Latin America:
354,000,000 €+1.7%
Africa:
44,000,000 €-58.9%
Total:
5,704,000,000 €+0.5%
Earnings release date:14 Mar. 24
North America:
743,000,000 €+11.4%
Europe:
4,156,000,000 €+5.8%
Asia-Pacific:
324,000,000 €-26.2%
Latin America:
348,000,000 €-10.3%
Africa:
107,000,000 €+13.8%
Total:
5,678,000,000 €+2.9%
Earnings release date:06 Nov. 23
North America:
667,000,000 €-83.3%
Europe:
3,930,000,000 €-15.1%
Asia-Pacific:
439,000,000 €-56.4%
Latin America:
388,000,000 €-33.3%
Africa:
94,000,000 €-31.4%
Total:
5,518,000,000 €-46.7%
Earnings release date:04 Aug. 23
North America:
4,004,000,000 €+2.8%
Europe:
4,630,000,000 €-0.5%
Asia-Pacific:
1,006,000,000 €-2.3%
Latin America:
582,000,000 €+6.6%
Africa:
137,000,000 €+37.0%
Total:
10,359,000,000 €+1.3%
Earnings release date:11 May. 23
North America:
3,894,000,000 €-7.4%
Europe:
4,655,000,000 €-0.9%
Asia-Pacific:
1,030,000,000 €-0.6%
Latin America:
546,000,000 €-0.2%
Africa:
100,000,000 €-35.9%
Total:
10,225,000,000 €-3.9%
Earnings release date:23 Mar. 23
North America:
4,205,000,000 €-0.5%
Europe:
4,699,000,000 €+7.6%
Asia-Pacific:
1,036,000,000 €-5.6%
Latin America:
547,000,000 €-13.4%
Africa:
156,000,000 €+13.9%
Total:
10,643,000,000 €+1.8%
Earnings release date:03 Nov. 22
North America:
4,226,000,000 €+7.9%
Europe:
4,367,000,000 €-1.4%
Asia-Pacific:
1,097,000,000 €+9.3%
Latin America:
632,000,000 €+19.0%
Africa:
137,000,000 €+0.0%
Total:
10,459,000,000 €+4.4%
Earnings release date:04 Aug. 22
North America:
3,916,000,000 €+4.2%
Europe:
4,430,000,000 €+1.1%
Asia-Pacific:
1,004,000,000 €+0.0%
Latin America:
531,000,000 €+12.5%
Africa:
137,000,000 €+31.7%
Total:
10,018,000,000 €+3.1%
Earnings release date:06 May. 22
North America:
3,759,000,000 €
Europe:
4,381,000,000 €
Asia-Pacific:
1,004,000,000 €
Latin America:
472,000,000 €
Africa:
104,000,000 €
Total:
9,720,000,000 €

Operating expenses

Operating expensesTable view

Earnings release date
Cost of revenue
Selling, general and administrative expenses
Research and development expenses
Total
Earnings release date:06 May. 26
Cost of revenue:
4,284,000,000 €-7.5%
Selling, general and administrative expenses:
743,000,000 €-9.8%
Research and development expenses:
163,000,000 €-4.1%
Total:
5,190,000,000 €-7.7%
Earnings release date:25 Mar. 26
Cost of revenue:
4,632,000,000 €+10.7%
Selling, general and administrative expenses:
824,000,000 €+21.9%
Research and development expenses:
170,000,000 €+6.9%
Total:
5,626,000,000 €+12.1%
Earnings release date:05 Nov. 25
Cost of revenue:
4,185,000,000 €+1.5%
Selling, general and administrative expenses:
676,000,000 €-8.6%
Research and development expenses:
159,000,000 €-3.0%
Total:
5,020,000,000 €-0.1%
Earnings release date:06 Aug. 25
Cost of revenue:
4,123,000,000 €-2.8%
Selling, general and administrative expenses:
740,000,000 €+15.1%
Research and development expenses:
164,000,000 €+17.1%
Total:
5,027,000,000 €+0.1%
Earnings release date:07 May. 25
Cost of revenue:
4,240,000,000 €+0.6%
Selling, general and administrative expenses:
643,000,000 €-12.3%
Research and development expenses:
140,000,000 €-20.9%
Total:
5,023,000,000 €-2.0%
Earnings release date:26 Mar. 25
Cost of revenue:
4,215,000,000 €+5.3%
Selling, general and administrative expenses:
733,000,000 €+4.6%
Research and development expenses:
177,000,000 €+4.1%
Total:
5,125,000,000 €+5.1%
Earnings release date:06 Nov. 24
Cost of revenue:
4,003,000,000 €-5.5%
Selling, general and administrative expenses:
701,000,000 €-12.7%
Research and development expenses:
170,000,000 €+9.7%
Total:
4,874,000,000 €-6.2%
Earnings release date:31 Jul. 24
Cost of revenue:
4,237,000,000 €-1.4%
Selling, general and administrative expenses:
803,000,000 €+13.4%
Research and development expenses:
155,000,000 €+11.5%
Total:
5,195,000,000 €+1.0%
Earnings release date:08 May. 24
Cost of revenue:
4,298,000,000 €-1.9%
Selling, general and administrative expenses:
708,000,000 €-22.1%
Research and development expenses:
139,000,000 €-31.9%
Total:
5,145,000,000 €-6.4%
Earnings release date:14 Mar. 24
Cost of revenue:
4,381,000,000 €+3.2%
Selling, general and administrative expenses:
909,000,000 €+20.2%
Research and development expenses:
204,000,000 €+20.0%
Total:
5,494,000,000 €+6.2%
Earnings release date:06 Nov. 23
Cost of revenue:
4,246,000,000 €-47.1%
Selling, general and administrative expenses:
756,000,000 €-52.4%
Research and development expenses:
170,000,000 €-15.4%
Total:
5,172,000,000 €-47.3%
Earnings release date:04 Aug. 23
Cost of revenue:
8,026,000,000 €+4.0%
Selling, general and administrative expenses:
1,589,000,000 €+4.1%
Research and development expenses:
201,000,000 €+1.5%
Total:
9,816,000,000 €+4.0%
Earnings release date:11 May. 23
Cost of revenue:
7,714,000,000 €-1.8%
Selling, general and administrative expenses:
1,526,000,000 €-24.7%
Research and development expenses:
198,000,000 €-28.5%
Total:
9,438,000,000 €-7.1%
Earnings release date:23 Mar. 23
Cost of revenue:
7,859,000,000 €+1.4%
Selling, general and administrative expenses:
2,026,000,000 €+25.8%
Research and development expenses:
277,000,000 €+32.5%
Total:
10,162,000,000 €+6.2%
Earnings release date:03 Nov. 22
Cost of revenue:
7,754,000,000 €+5.6%
Selling, general and administrative expenses:
1,610,000,000 €-1.3%
Research and development expenses:
209,000,000 €+3.5%
Total:
9,573,000,000 €+4.4%
Earnings release date:04 Aug. 22
Cost of revenue:
7,340,000,000 €+2.5%
Selling, general and administrative expenses:
1,631,000,000 €+10.4%
Research and development expenses:
202,000,000 €+12.8%
Total:
9,173,000,000 €+4.0%
Earnings release date:06 May. 22
Cost of revenue:
7,162,000,000 €
Selling, general and administrative expenses:
1,477,000,000 €
Research and development expenses:
179,000,000 €
Total:
8,818,000,000 €

Profitability

ProfitabilityTable view

Earnings release date
Net income (shareholders)
Free cash flow
Total
Earnings release date:06 May. 26
Net income (shareholders):
435,000,000 €+20.5%
Free cash flow:
193,000,000 €-77.6%
Total:
628,000,000 €-48.6%
Earnings release date:25 Mar. 26
Net income (shareholders):
361,000,000 €+4.9%
Free cash flow:
860,000,000 €+64.1%
Total:
1,221,000,000 €+40.7%
Earnings release date:05 Nov. 25
Net income (shareholders):
344,000,000 €+4.2%
Free cash flow:
524,000,000 €+136.0%
Total:
868,000,000 €+57.2%
Earnings release date:06 Aug. 25
Net income (shareholders):
330,000,000 €+44.1%
Free cash flow:
222,000,000 €+311.4%
Total:
552,000,000 €+345.2%
Earnings release date:07 May. 25
Net income (shareholders):
229,000,000 €-4.6%
Free cash flow:
-105,000,000 €-117.4%
Total:
124,000,000 €-85.3%
Earnings release date:26 Mar. 25
Net income (shareholders):
240,000,000 €-26.4%
Free cash flow:
604,000,000 €+13.5%
Total:
844,000,000 €-1.6%
Earnings release date:06 Nov. 24
Net income (shareholders):
326,000,000 €+187.4%
Free cash flow:
532,000,000 €-0.9%
Total:
858,000,000 €+423.2%
Earnings release date:31 Jul. 24
Net income (shareholders):
-373,000,000 €-234.2%
Free cash flow:
537,000,000 €+375.4%
Total:
164,000,000 €+97.6%
Earnings release date:08 May. 24
Net income (shareholders):
278,000,000 €+145.3%
Free cash flow:
-195,000,000 €-122.3%
Total:
83,000,000 €-68.2%
Earnings release date:14 Mar. 24
Net income (shareholders):
-614,000,000 €-51.2%
Free cash flow:
875,000,000 €+166.8%
Total:
261,000,000 €+434.6%
Earnings release date:06 Nov. 23
Net income (shareholders):
-406,000,000 €-607.5%
Free cash flow:
328,000,000 €-58.2%
Total:
-78,000,000 €-109.0%
Earnings release date:04 Aug. 23
Net income (shareholders):
80,000,000 €-76.9%
Free cash flow:
785,000,000 €+529.0%
Total:
865,000,000 €+430.7%
Earnings release date:11 May. 23
Net income (shareholders):
346,000,000 €+35.7%
Free cash flow:
-183,000,000 €-116.7%
Total:
163,000,000 €-87.9%
Earnings release date:23 Mar. 23
Net income (shareholders):
255,000,000 €-20.6%
Free cash flow:
1,094,000,000 €+25.7%
Total:
1,349,000,000 €+13.3%
Earnings release date:03 Nov. 22
Net income (shareholders):
321,000,000 €-16.2%
Free cash flow:
870,000,000 €+50.5%
Total:
1,191,000,000 €+23.9%
Earnings release date:04 Aug. 22
Net income (shareholders):
383,000,000 €-7.3%
Free cash flow:
578,000,000 €+321.5%
Total:
961,000,000 €+532.2%
Earnings release date:06 May. 22
Net income (shareholders):
413,000,000 €
Free cash flow:
-261,000,000 €
Total:
152,000,000 €

Profit margin in %

Profit margin in %Table view

Earnings release date
Profit margin (shareholders)
Profit margin (free cash flow)
Earnings release date:06 May. 26
Profit margin (shareholders):
7.57 %+1.4 pp
Profit margin (free cash flow):
3.36 %-11.3 pp
Earnings release date:25 Mar. 26
Profit margin (shareholders):
6.14 %-0.1 pp
Profit margin (free cash flow):
14.64 %+5.1 pp
Earnings release date:05 Nov. 25
Profit margin (shareholders):
6.28 %+0.4 pp
Profit margin (free cash flow):
9.57 %+5.6 pp
Earnings release date:06 Aug. 25
Profit margin (shareholders):
5.92 %+1.9 pp
Profit margin (free cash flow):
3.98 %+5.8 pp
Earnings release date:07 May. 25
Profit margin (shareholders):
4.07 %-0.3 pp
Profit margin (free cash flow):
-1.86 %-12.8 pp
Earnings release date:26 Mar. 25
Profit margin (shareholders):
4.34 %-1.8 pp
Profit margin (free cash flow):
10.93 %+0.9 pp
Earnings release date:06 Nov. 24
Profit margin (shareholders):
6.15 %+13.0 pp
Profit margin (free cash flow):
10.03 %+0.1 pp
Earnings release date:31 Jul. 24
Profit margin (shareholders):
-6.89 %-11.8 pp
Profit margin (free cash flow):
9.92 %+13.3 pp
Earnings release date:08 May. 24
Profit margin (shareholders):
4.87 %+15.7 pp
Profit margin (free cash flow):
-3.42 %-18.8 pp
Earnings release date:14 Mar. 24
Profit margin (shareholders):
-10.81 %-3.5 pp
Profit margin (free cash flow):
15.41 %+9.5 pp
Earnings release date:06 Nov. 23
Profit margin (shareholders):
-7.36 %-8.1 pp
Profit margin (free cash flow):
5.94 %-1.6 pp
Earnings release date:04 Aug. 23
Profit margin (shareholders):
0.77 %-2.6 pp
Profit margin (free cash flow):
7.58 %+9.4 pp
Earnings release date:11 May. 23
Profit margin (shareholders):
3.38 %+1.0 pp
Profit margin (free cash flow):
-1.79 %-12.1 pp
Earnings release date:23 Mar. 23
Profit margin (shareholders):
2.4 %-0.7 pp
Profit margin (free cash flow):
10.28 %+2.0 pp
Earnings release date:03 Nov. 22
Profit margin (shareholders):
3.07 %-0.8 pp
Profit margin (free cash flow):
8.32 %+2.5 pp
Earnings release date:04 Aug. 22
Profit margin (shareholders):
3.82 %-0.4 pp
Profit margin (free cash flow):
5.77 %+8.5 pp
Earnings release date:06 May. 22
Profit margin (shareholders):
4.25 %
Profit margin (free cash flow):
-2.69 %